FDA puts Curis' leukemia trial on partial hold after patient death spurs review of...

[cafead]

via The list of biotechs under clinical hold keeps getting longer. Curis is the latest company to join the list, with the FDA slapping a partial hold on a phase 1/2a leukemia study while it gathers information about the death of a patient.

article source